Mitochondrial Haplogroups Modify the Risk of Developing Hypertrophic Cardiomyopathy in a Danish Population

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Hagen, Christian M ^a,b   Aidt, Frederik H ^a   Hedley, Paula L ^a,c   Jensen, Morten K ^d   Havndrup, Ole ^e   Kanters, Jørgen K ^b,f   Moolman Smook, Johanna C ^c   Larsen, Severin O ^a   Bundgaard, Henning ^d   Christiansen, Michael ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d Heart Center   (Denmark)

^e ROSKILDE HOSPITAL   (Denmark)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA DETERMINATION; DNA ISOLATION; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE IDENTIFICATION; HAPLOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL GENOME; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SHORT TANDEM REPEAT;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; DENMARK; DNA, MITOCHONDRIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; PHYLOGENY; RISK FACTORS;

EID: 84881103197     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071904     Document Type: Article

References (46)

1. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B, (2007) Mitochondria, oxidative stress and cell death. Apoptosis 12: 913-922. doi:10.1007/s10495-007-0756-2. PubMed: 17453160.
2. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, et al. (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23: 147. doi:10.1038/13779. PubMed: 10508508.
3. Martínez-Redondo D, Marcuello A, Casajús JA, Ara I, Dahmani Y, et al. (2010) Human mitochondrial haplogroup H: the highest VO2max consumer--is it a paradox? Mitochondrion 10: 102-107. doi:10.1016/j.mito.2009.11.005. PubMed: 19900587.
4. Ji Y, Zhang AM, Jia X, Zhang YP, Xiao X, et al. (2008) Mitochondrial DNA haplogroups M7b1'2 and M8a affect clinical expression of leber hereditary optic neuropathy in Chinese families with the m.11778G-- >a mutation. Am J Hum Genet 83: 760-768. doi:10.1016/j.ajhg.2008.11.002. PubMed: 19026397.
5. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, et al. (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72: 804-811. doi:10.1086/373937. PubMed: 12618962.
6. van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, et al. (2004) Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365: 28-32. doi:10.1016/j.neulet.2004.04.051. PubMed: 15234467.
7. Chinnery PF, Elliott HR, Syed A, Rothwell PM, (2010) Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study. Lancet Neurol 9: 498-503. doi:10.1016/S1474-4422(10)70083-1. PubMed: 20362514.
8. Fernández-Caggiano M, Barallobre-Barreiro J, Rego-Pérez I, Crespo-Leiro MG, Paniagua MJ, et al. (2012) Mitochondrial haplogroups H and J: risk and protective factors for ischemic cardiomyopathy. PLOS ONE 7: e44128. doi:10.1371/journal.pone.0044128. PubMed: 22937160.
9. Rosca MG, Hoppel CL, (2010) Mitochondria in heart failure. Cardiovasc Res 88: 40-50. doi:10.1093/cvr/cvq240. PubMed: 20668004.
10. Tsutsui H, Kinugawa S, Matsushima S, (2009) Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 81: 449-456. PubMed: 18854381.
11. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, et al. (2003) Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. JPhysiol 551: 491-501.
12. Abel ED, Doenst T, (2011) Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc Res 90: 234-242. doi:10.1093/cvr/cvr015. PubMed: 21257612.
13. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE, (1987) Hypertrophic cardiomyopathy. Interrelations Clinical Manifestations Pathophysiol And Therapy (1) N EnglJMed 316: 780-789.
14. Andersen PS, Havndrup O, Hougs L, Sørensen KM, Jensen M, et al. (2009) Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum Mutat 30: 363-370. doi:10.1002/humu.20862. PubMed: 19035361.
15. Towbin JA, (2009) Hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 32 (Suppl 2):: S23-S31. doi:10.1111/j.1540-8159.2009.02381.x. PubMed: 19602159.
16. Castro MG, Huerta C, Reguero JR, Soto MI, Doménech E, et al. (2006) Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy. Int J Cardiol 112: 202-206. doi:10.1016/j.ijcard.2005.09.008. PubMed: 16313983.
17. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF, (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83: 254-260. doi:10.1016/j.ajhg.2008.07.004. PubMed: 18674747.
18. mitomap.org; (2012). www.mitomap.org (Accessed 2012).
19. ten Cate FJ, Hugenholtz PG, van Dorp WG, Roelandt J, (1979) Prevalence of dignostic abnormalities in patients with genetically transmitted asymmetric septal hypertrophy. Am J Cardiol 43: 731-737. doi:10.1016/0002-9149(79)90071-7. PubMed: 570800.
20. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93: 841-842. doi:10.1161/01.CIR.93.5.841. PubMed: 8598070.
21. Havndrup O, Christiansen M, Stoevring B, Jensen M, Hoffman-Bang J, et al. (2010) Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. Eur J Heart Fail 12: 535-540. doi:10.1093/eurjhf/hfq073. PubMed: 20498269.
22. Hedley PL, Haundrup O, Andersen PS, Aidt FH, Jensen M, et al. (2011) The KCNE genes in hypertrophic cardiomyopathy: a candidate gene study. J Negat Results Biomed 10: 12. doi:10.1186/1477-5751-10-12. PubMed: 21967835.
23. Rousset F, (2008) genepop'007: a complete re-implementation of the genepop software for Windows and Linux. Mol Ecol Resour 8: 103-106. doi:10.1111/j.1471-8286.2007.01931.x. PubMed: 21585727.
24. Benn M, Schwartz M, Nordestgaard BG, Tybjaerg-Hansen A, (2008) Mitochondrial haplogroups: ischemic cardiovascular disease, other diseases, mortality, and longevity in the general population. Circulation 117: 2492-2501. doi:10.1161/CIRCULATIONAHA.107.756809. PubMed: 18458168.
25. Mikkelsen M, Sørensen E, Rasmussen EM, Morling N, (2010) Mitochondrial DNA HV1 and HV2 variation in Danes. Forensic Sci Int Genet 4: e87-e88. doi:10.1016/j.fsigen.2009.07.007. PubMed: 20457038.
26. van Oven M, Kayser M, (2009) Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat 30: E386-E394. doi:10.1002/humu.20921. PubMed: 18853457.
27. Gómez-Durán A, Pacheu-Grau D, López-Gallardo E, Díez-Sánchez C, Montoya J, et al. (2010) Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 19: 3343-3353. doi:10.1093/hmg/ddq246. PubMed: 20566709.
28. Beckstead WA, Ebbert MT, Rowe MJ, McClellan DA, (2009) Evolutionary pressure on mitochondrial cytochrome b is consistent with a role of CytbI7T affecting longevity during caloric restriction. PLOS ONE 4: e5836. doi:10.1371/journal.pone.0005836. PubMed: 19503808.
29. Murphy MP, (2009) How mitochondria produce reactive oxygen species. Biochem J 417: 1-13. doi:10.1042/BJ20082215. PubMed: 19061483.
30. Rosca MG, Hoppel CL, (2009) New aspects of impaired mitochondrial function in heart failure. J Bioenerg Biomembr 41: 107-112. doi:10.1007/s10863-009-9215-9. PubMed: 19347572.
31. Vonck J, Schäfer E, (2009) Supramolecular organization of protein complexes in the mitochondrial inner membrane. Biochim Biophys Acta 1793: 117-124. doi:10.1016/j.bbamcr.2008.05.019. PubMed: 18573282.
32. Seelert H, Dani DN, Dante S, Hauss T, Krause F, et al. (2009) From protons to OXPHOS supercomplexes and Alzheimer's disease: structure-dynamics-function relationships of energy-transducing membranes. Biochim Biophys Acta 1787: 657-671. doi:10.1016/j.bbabio.2009.02.028. PubMed: 19281792.
33. Marcuello A, Martínez-Redondo D, Dahmani Y, Terreros JL, Aragonés T, et al. (2009) Steady exercise removes VO(2max) difference between mitochondrial genomic variants. Mitochondrion 9: 326-330. doi:10.1016/j.mito.2009.04.007. PubMed: 19427920.
34. Korshunov SS, Skulachev VP, Starkov AA, (1997) High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416: 15-18. doi:10.1016/S0014-5793(97)01159-9. PubMed: 9369223.
35. Finkel T, (2003) Oxidant signals and oxidative stress. Curr Opin Cell Biol 15: 247-254. doi:10.1016/S0955-0674(03)00002-4. PubMed: 12648682.
36. Dröge W, (2002) Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95. PubMed: 11773609.
37. Grieve DJ, Shah AM, (2003) Oxidative stress in heart failure. More than just damage. Eur Heart J 24: 2161-2163. doi:10.1016/j.ehj.2003.10.015. PubMed: 14659766.
38. Valenti L, Conte D, Piperno A, Dongiovanni P, Fracanzani AL, et al. (2004) The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. Med Genet 41: 946-950. doi:10.1136/jmg.2004.019588. PubMed: 15591282.
39. Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, et al. (2000) Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 86: 152-157. doi:10.1161/01.RES.86.2.152. PubMed: 10666410.
40. Mallat Z, Philip I Lebret M, Chatel D, Maclouf Jet al. (1998) Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97: 1536-1539. doi:10.1161/01.CIR.97.16.1536. PubMed: 9593557.
41. Xu Q, Dewey S, Nguyen S, Gomes AV, (2010) Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes. J Mol Cell Cardiol 48: 899-909. doi:10.1016/j.yjmcc.2010.03.005. PubMed: 20298698.
42. Brand MD, (2010) The sites and topology of mitochondrial superoxide production. Exp Gerontol 45: 466-472. doi:10.1016/j.exger.2010.01.003. PubMed: 20064600.
43. Zielonka J, Kalyanaraman B, (2008) "ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis"--a critical commentary. Free Radic Biol Med 45: 1217-1219. doi:10.1016/j.freeradbiomed.2008.07.025. PubMed: 18789385.
44. Kalman B, Li S, Chatterjee D, O'Connor J, Voehl MR, et al. (1999) Large scale screening of the mitochondrial DNA reveals no pathogenic mutations but a haplotype associated with multiple sclerosis in Caucasians. Acta Neurol Scand 99: 16-25. doi:10.1111/j.1600-0447.1999.tb05380.x. PubMed: 9925234.
45. Dato S, Passarino G, Rose G, Altomare K, Bellizzi D, et al. (2004) Association of the mitochondrial DNA haplogroup J with longevity is population specific. EurJHumGenet 12: 1080-1082.
46. Pinos T, Nogales-Gadea G, Ruiz JR, Rodriguez-Romo G, Santiago-Dorrego C, et al. (2011) Are mitochondrial haplogroups associated with extreme longevity? A study on a Spanish cohort. Age (Dordr).